Has Tiffany Alexander, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,358 in general payments to Tiffany Alexander, MD across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tiffany Alexander, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tiffany Alexander, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tiffany Alexander, MD

Dermatology · Wilson, NCNPI 1851824288

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.7% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,935, more than ten times the $110 reported in 2021.

$4,358in general payments, 2019–2025

Across 132 payments — averaging $33.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$826
Sanofi$532
LEO Pharma Inc.$380
Regeneron Healthcare Solutions, Inc.$324
UCB, Inc.$296
Galderma Laboratories, L.p.$283
plus $2K from 17 others

What the payments were for

Food & beverage$4,04093%
Education$3187%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	38	$826
Sanofi	14	$532
LEO Pharma Inc.	6	$380
Regeneron Healthcare Solutions, Inc.	8	$324
UCB, Inc.	6	$296
Galderma Laboratories, L.p.	7	$283
Johnson & Johnson	6	$283
Novartis	6	$257
Amgen	5	$176
Lilly USA, LLC	7	$149
Incyte Corporation	3	$147
Dermavant Sciences, Inc.	2	$132
E.r. Squibb & Sons, L.L.C.	5	$110
Sanofi-aventis U.S. LLC	1	$90
Pfizer	4	$70
Otsuka America Pharmaceutical, Inc.	3	$66
Arcutis Biotherapeutics, Inc.	2	$51
Helsinn Therapeutics (U.S.), Inc.	3	$48
Organogenesis Inc.	1	$38
Boehringer Ingelheim	2	$35
Almirall LLC	1	$25
Sun Pharmaceutical Industries Inc.	1	$21
EPI Health, LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ADBRY$144
ANZUPGO$138
COSENTYX$136
VTAMA$127
Tremfya$125
Bimzelx$124
OPZELURA$110

How this compares

$4,358 in reported general payments places this provider in the 65th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$109,184

Medicare patients

419

Services billed

1,746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	13	$48,008
Clobetasol Propionate	108	$4,461
Ketoconazole	126	$1,718
Clindamycin Phosphate	39	$1,697
Fluocinolone AcetonideFluocinolone/Shower Cap	27	$1,282
Doxycycline Hyclate	106	$1,258
Tacrolimus	15	$1,185
Desonide	23	$856
Triamcinolone Acetonide	75	$856
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	16	$801
Metronidazole	14	$708
Ciclopirox	16	$376
Mupirocin	50	$230
Hydroxyzine Hcl	13	$193
Hydrocortisone	41	$164

Paid to pharmacies, not to this prescriber.

Other dermatology in Wilson

Steven FeldmanWinston Salem$3.4M
Nicole SeminaraHuntersville$1.4M
Andrew LeeElkin$702K
Christopher SayedChapel Hill$690K
William HooverConcord$594K
Patrick McElgunnCharlotte$565K
George MagelHickory$554K
Muneeb ShahClinton$451K
John SoderbergCary$398K
Rosalyn GeorgeWilmington$346K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →